Today's Featured Company
Champions Biotechnology, Inc. is engaged in the development of advanced preclinical platforms and predictive tumor specific data to enhance and accelerate the value of oncology drugs. The Company’s Preclinical Platform is a novel approach based upon the implantation of primary human tumors in immune deficient mice followed by propagation of the resulting xenografts (Biomerk Tumorgrafts™) in a manner that preserves the biological characteristics of the original human tumor.
Featured Videos
Recent News
mPhase Technologies, Inc. (OTC BB: XDSL), the global leader in the development of Power On Command™ reserve battery technology, today announced the launch of mPowertech.com, a website that features an online store through which the company’s mPower Emergency Illuminator will be made available for sale worldwide.
mPhase Technologies, Inc. (OTC BB: XDSL), the global leader in the development of Power On Command™ reserve battery technology, today announced that its consumer products division, mPower Technologies, Inc., has received an additional Innovations Design and Engineering Award at the 2010 International Consumer Electronics Show (CES) in Las Vegas. mPower Technologies has been presented the additional award in the "Portable Power" category for its mPower Emergency Illuminator.
IRGnews Podcast
Episode 28: PolyMedix
On the 28th episode of the IRGnews Podcast, we are speaking with Nicholas Landekic, the CEO and President of PolyMedix, about the novel antibiotic compounds and heptagonists his biotechnology company is developing. Nick explains how his company is addressing both the serious issue of antibiotic resistance and the unmet medical need for an alternative to protamine, a reversing agent for the anticoagulant, heparin. As always, we will also be highlighting all of the exciting news from around IRGnews.com
